1 / 6

Alpha- Antitrypsin Deficiency Global Clinical Trials Review

“Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Get Full Report at: http://www.researchbeam.com/alpha-antitrypsin-deficiency-global-clinical-trials-review-h1-2015-market

BretSZavala
Download Presentation

Alpha- Antitrypsin Deficiency Global Clinical Trials Review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESEARCH BEAM SIZE FORECAST RESEARCH DEMAND Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015 AND SIZE MARKET AND & RESEARCH RESEARCH RESEARCH MARKET SIZE FORECAST RESEARCH DEMAND AND SIZE MARKET AND & RESEARCH RESEARCH • TELEPHONE: +1 (855) 711-1555E-MAIL:sales@researchbeam.com FORECAST

  2. ReportOverview Summary GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Get Full Report at: http://www.researchbeam.com/alpha-antitrypsin-deficiency-global-clinical-trials-review-h1-2015-market

  3. ReportOverview • Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated)

  4. ReportOverview • Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

  5. Tables of Contents Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Alpha- Antitrypsin Deficiency 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by G7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 16 Clinical Trials by Phase 17

  6. Contact Enquire About Report: http://www.researchbeam.com/alpha-antitrypsin-deficiency-global-clinical-trials-review-h1-2015-market/enquire-about-report • TELEPHONE: +1 (855) 711-1555E-MAIL:help@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related